Weight-loss strategies to protect your heart
Obesity is a common, chronic disease that can harm the heart. The powerful weight-loss medications known as GLP-1s, semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), are now recommended as first-line therapy for eligible people, according to the American College of Cardiology. People using these drugs should work with a dietitian or nutritionist who can help them create a personalized eating plan that ensures they’re getting enough nutrients while minimizing common side effects.
Content restricted. Requires subscription